Regeneron Pharmaceuticals Inc. buy Wells Fargo & Company
Start price
02.08.24
/
50%
€992.60
Target price
02.08.25
€1,099.3
Performance (%)
-51.42%
End price
03.08.25
€482.20
Summary
This prediction ended on 03.08.25 with a price of €482.20. Massive losses of -51.42% were the result for the BUY prediction by Wells_Fargo___Compan. Wells_Fargo___Compan has a follow-up prediction for Regeneron Pharmaceuticals Inc. where he still thinks Regeneron Pharmaceuticals Inc. is a Buy. Dividends of €1.72 are taken into consideration when calculating the performance. Wells_Fargo___Compan has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Regeneron Pharmaceuticals Inc. | -6.440% | -6.440% | -17.947% |
| iShares Core DAX® | 1.917% | 1.088% | 17.187% |
| iShares Nasdaq 100 | 0.911% | 1.674% | 7.930% |
| iShares Nikkei 225® | 0.833% | -1.712% | 12.100% |
| iShares S&P 500 | 0.242% | 1.258% | 3.167% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) had its price target raised by analysts at Wells Fargo & Company from $1,125.00 to $1,200.00. They now have an "overweight" rating on the stock.
Ratings data for REGN provided by MarketBeat
In the thread Trading Regeneron Pharmaceuticals Inc.
Die von Wells_Fargo___Compan gewählte maximale Laufzeit wurde überschritten
Current prediction by Wells_Fargo___Compan for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€693.60
10.01.25
10.01.25
€875.97
10.01.26
10.01.26
-12.65%
18:15
18:15
Stopped prediction by Wells_Fargo___Compan for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€519.00
30.04.25
30.04.25
€615.65
30.04.26
30.04.26
16.58%
18:15
18:15
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€995.60
23.09.24
23.09.24
€1,078.7
23.09.25
23.09.25
-51.79%
24.09.25
24.09.25